IMARC Group, a leading market research company, has recently releases report titled “India Genetic Testing Market Report by Type (Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing and Chromosome Analysis, Biochemical Testing, Molecular Testing), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others), and Region 2024-2032”. India genetic testing market size is projected to exhibit a growth rate (CAGR) of 7.11% during 2024-2032.
Advancements in genomic research as well as the growing consciousness of personalized medicine are the factors responsible for the growth of the India genetic testing market. Additionally, the market is expanding owing to the rising demand for genetic testing in the diagnosis and management of various hereditary conditions and cancers. As healthcare providers and patients become more informed about the benefits of early detection and targeted treatments, the adoption of genetic testing is expanding. This shift is particularly evident in oncology, where genetic tests help identify specific mutations that can be targeted with personalized therapies, improving treatment outcomes and reducing side effects. Moreover, the growing prevalence of genetic disorders in the population is further bolstering the need for diagnostic genetic testing.
Request to Get the Sample Report: https://www.imarcgroup.com/india-genetic-testing-market/requestsample
India Genetic Testing Market
Technological advancements and increased accessibility to genetic testing are significant drivers in the India genetic testing market. In addition to this, the development of more affordable and accurate next-generation sequencing technologies has made genetic testing more accessible to a broader segment of the population, which is acting as another growth-inducing factor. Furthermore, initiatives and policies introduced by government authorities aimed at improving healthcare infrastructures and promoting research and development in genomics are supporting market growth. The rise of direct-to-consumer genetic testing services is also noteworthy, as it empowers individuals to proactively manage their health and make informed decisions about their medical care, which is anticipated to drive the India genetic testing market over the forecasted period.
India Genetic Testing Market Segmentation
Type Insights:
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Testing
- Diagnostic Testing
- Pharmacogenomic Testing
- Others
Technology Insights:
- Cytogenetic Testing and Chromosome Analysis
- Biochemical Testing
- Molecular Testing
- DNA Sequencing
- Others
Application Insights:
- Cancer Diagnosis
- Genetic Disease Diagnosis
- Cardiovascular Disease Diagnosis
- Others
Regional Insights:
- North India
- West and Central India
- South India
- East and Northeast India
Ask Analyst for Customization and Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=21433&flag=C
Key Highlights of the Report:
• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Sign in to leave a comment.